Efficacy and safety of elranatamab in pts with relapsed/ refractory multiple myeloma (RRMM) and prior B-cell maturation antigen (BCMA)-directed therapies: A pooled analysis from MagnetisMM studies Meeting Abstract


Authors: Raab, M. S.; Hanel, M.; Nooka, A. K.; Lesokhin, A. M.; Mohty, M.; Niesvizky, R.; Maisel, C.; Arnulf, B.; Larson, S. M.; Varshavsky-Yanovsky, A. N.; Leleu, X.; Karlin, L.; Vesole, D. H.; Bahlis, N. J.; de Larrea, C. F.; Raje, N.; Leip, E.; Conte, U.; Elmeliegy, M.; Viqueira, A.; Manier, S.
Abstract Title: Efficacy and safety of elranatamab in pts with relapsed/ refractory multiple myeloma (RRMM) and prior B-cell maturation antigen (BCMA)-directed therapies: A pooled analysis from MagnetisMM studies
Meeting Title: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (2023)
Journal Title: Oncology Research and Treatment
Volume: 46
Issue: Suppl. 5
Meeting Dates: 2023 Oct 13-16
Meeting Location: Hamburg, Germany
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2023-10-01
Start Page: 232
Language: English
ACCESSION: WOS:001091456900507
PROVIDER: wos
PUBMED: 37788643
DOI: 10.1159/000533576
Notes: Meeting Abstract: P673 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Meyer Lesokhin
    374 Lesokhin